| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Headaches | 2 | 1 | |
| Angina pectoris | 1 | 1 | |
| Antiphospholipid antibody syndrome | 1 | 1 | |
| Prevent blood clotting | 1 | 0 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 1 |
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Headaches | 2 | 1 | |
| Angina pectoris | 1 | 1 | |
| Antiphospholipid antibody syndrome | 1 | 1 | |
| Prevent blood clotting | 1 | 0 |
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 0 | |
| None | 1 |